Hee Won Yang

9PUBLICATIONS
22CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHaematological tumoursGene expression (incl. microarray and other genome-wide approaches)Microfluidics and nanofluidics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Dec 29, 2025
Therapeutic benefits of maintaining CDK4/6 inhibitors and incorporating CDK2 inhibitors beyond progression in breast cancer.

Jessica Armand, Sungsoo Kim, Kibum Kim

|Jul 21, 2025
E2F activity determines mitosis versus whole-genome duplication in G2-arrested cells.

Kibum Kim, Jessica Armand, Sungsoo Kim

|Feb 10, 2025
Targeting CDK4/6 in breast cancer.

Anusha Shanabag, Jessica Armand, Eugene Son

|Nov 28, 2024
Therapeutic benefits of maintaining CDK4/6 inhibitors and incorporating CDK2 inhibitors beyond progression in breast cancer.

Jessica Armand, Sungsoo Kim, Kibum Kim

|Nov 29, 2023
Non-canonical pathway for Rb inactivation and external signaling coordinate cell-cycle entry without CDK4/6 activity.

Mimi Zhang, Sungsoo Kim, Hee Won Yang

|Apr 24, 2023
Angiopoietin-2-Dependent Spatial Vascular Destabilization Promotes T-cell Exclusion and Limits Immunotherapy in Melanoma.

Ha-Ram Park, Anahita Shiva, Portia Cummings

Pageof 2

Frequent Collaborators

3 joint publications

Sungsoo Kim

1 joint publications

Arnold Hayer

1 joint publications

Mingyu Chung

1 joint publications

Anjali Bisaria